文献速递骨质疏松与代谢性骨病

全外显子组筛查发现骨密度新的罕见风险变异

Exome-wide screening identifies novel rare risk variants for bone mineral density.
PubMed 文献 · Osteoporos Int · 2023-02-28

研究利用英国生物银行200643例外显子组数据,在男性和女性中分别进行基于基因的外显子组范围关联研究,通过多基因风险评分筛选低30%个体,比较骨密度最高10%与最低10%者,经质量控制后男性741例、女性697例纳入骨密度分析,男性717例、女性708例纳入维生素D-骨密度分析,基于基因的负荷检验发现ANKRD18A、C22orf31、SPATC1L与骨密度在全基因组水平候选关联,维生素D-骨密度分析中NIPAL1等三个基因与骨密度相关。

要点

  • 基于基因的负荷检验发现ANKRD18A、C22orf31、SPATC1L与骨密度存在全基因组候选关联。
  • 维生素D-骨密度分析中NIPAL1等三个基因与骨密度相关。
  • 研究提示罕见变异对骨密度有贡献,为扩展骨密度遗传结构提供新视角。

核心结论

  • 研究提示罕见变异对骨密度有贡献,为扩展骨密度遗传结构提供新视角。

研究设计与样本

  • 利用新发布的英国生物银行200643例外显子组数据,在男性和女性中分别进行基于基因的外显子组范围关联研究。
  • 多基因风险评分分析纳入100639例男性和117338例女性且有骨密度值者,在较低30%多基因风险评分个体中,骨密度最高10%者为病例、骨密度最低10%者为对照。
  • 考虑维生素D效应,选择维生素D浓度最高30%个体进行维生素D-骨密度分析。
  • 质量控制后,骨密度分析纳入741例男性和697例女性,维生素D-骨密度分析纳入717例男性和708例女性。
  • 变异经ANNOVAR软件注释后,骨密度和维生素D-骨密度合格变异分别导入SKAT R包进行基于基因的负荷检验。

主要发现

  • 外显子变异的基于基因负荷检验发现ANKRD18A(P=1.60×10^-5,Bonferroni校正P=2.11×10^-3)、C22orf31(P=3.49×10^-4,Bonferroni校正P=3.17×10^-2)和SPATC1L(P=1.09×10^-5,Bonferroni校正P=8.80×10^-3)在全基因组水平候选关联。
  • 维生素D-骨密度分析中,NIPAL1(P=1.06×10^-3,Bonferroni校正P=3.91×10^-2)等三个基因与骨密度相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Bone mineral density (BMD) is an independent risk factor of osteoporosis-related fractures. We performed gene-based burden tests to assess the association between rare variants and BMD, and identified several BMD candidate genes. PURPOSE: BMD is highly heritable and a major predictor of osteoporotic fractures, but its genetic basis remains unclear. We aimed to identify rare risk variants contributing to BMD. METHODS: Utilizing the newly released UK Biobank 200,643 exome dataset, we conducted a gene-based exome-wide association study in males and females, respectively. First, 100,639 males and 117,338 females with BMD values were included in the polygenic risk scores (PRS) analysis. Among individuals with lower 30% PRS, cases were individuals with top 10% BMD, and individuals with bottom 10% BMD were the controls. Considering the effects of vitamin D (VD), individuals with the highest 30% VD concentration were selected for VD-BMD analysis. After quality control, 741 males and 697 females were included in the BMD analysis, and 717 males and 708 females were included in the VD-BMD analysis. The variants were annotated by ANNOVAR software, then BMD and VD-BMD qualified variants were imported into the SKAT R-package to perform gene-based burden tests, respectively. RESULTS: The gene-based burden test of the exonic variants identified genome-wide candidate associations in ANKRD18A (P = 1.60 × 10-5, PBonferroni adjust = 2.11 × 10-3), C22orf31 (P = 3.49 × 10-4, PBonferroni adjust = 3.17 × 10-2), and SPATC1L (P = 1.09 × 10-5, PBonferroni adjust = 8.80 × 10-3). For VD-BMD analysis, three genes were associated with BMD, such as NIPAL1 (P = 1.06 × 10-3, PBonferroni adjust = 3.91 × 10-2). CONCLUSIONS: Our study suggested that rare variants contribute to BMD, providing new sights for broadening the genetic structure of BMD.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. He D, Pan C, Zhao Y, et al. Exome-wide screening identifies novel rare risk variants for bone mineral density. Osteoporos Int. 2023. PMID: 36849660. doi:10.1007/s00198-023-06710-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。